Načítá se...
Efficiency of antiviral treatment in COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is responsible for generating a global effort to discover urgent therapeutic solutions to limit the human damage caused by COVID-19. In the period of April to June 2020, 105 patients diagnosed with COVID-19 met the conditions...
Uloženo v:
| Vydáno v: | Exp Ther Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097236/ https://ncbi.nlm.nih.gov/pubmed/33968179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10080 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|